Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,608 | -26,170 | -18,770 | -8,860 | -42,914 |
| Depreciation Amortization | 4,070 | 2,868 | 877 | 884 | 2,982 |
| Accounts receivable | -3,220 | -4,238 | -2,982 | -2,507 | 243 |
| Accounts payable and accrued liabilities | 2,088 | 469 | 1,712 | 1,947 | 1,025 |
| Other Working Capital | -2,655 | -2,631 | -3,348 | -3,102 | 16,757 |
| Other Operating Activity | 42,888 | 9,685 | 5,426 | 2,935 | 5,422 |
| Operating Cash Flow | $8,563 | $-20,017 | $-17,085 | $-8,703 | $-16,485 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -25,060 | -20,512 | -23,377 | -11,226 | -38,471 |
| PPE Investments | -4,986 | -4,695 | -3,949 | -1,484 | -1,947 |
| Other Investing Activity | 4,986 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-25,060 | $-25,207 | $-27,326 | $-12,710 | $-40,418 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,000 | 3,613 | 2,582 | 377 | 1,037 |
| Debt Repayment | -2,259 | -1,525 | -923 | -446 | -843 |
| Common Stock Issued | 164,890 | 62,847 | 62,659 | 62,551 | 52,423 |
| Financing Cash Flow | $166,631 | $64,935 | $64,318 | $62,482 | $52,617 |
| Exchange Rate Effect | 243 | 48 | -19 | -22 | -229 |
| Beginning Cash Position | 15,757 | 15,757 | 15,757 | 15,757 | 20,272 |
| End Cash Position | 127,955 | 35,516 | 35,645 | 56,804 | 15,757 |
| Net Cash Flow | $-16,497 | $19,759 | $19,888 | $41,047 | $-4,515 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,563 | -20,017 | -17,085 | -8,703 | -16,485 |
| Capital Expenditure | -4,986 | -4,695 | -3,949 | -1,484 | -1,947 |
| Free Cash Flow | 3,577 | -24,712 | -21,034 | -10,187 | -18,432 |